Sigut

Reagent of the month – Polytriazole ligands for the copper catalysed alkyne–azide cycloaddition (CuAAC)

October 2, 2024

The copper (i) catalysed alkyne–azide cycloaddition (CuAAC) is one of the most frequently used bioconjugation reactions nowadays. It was first reported in 2002 independently by the labs of M. Meldal (https://doi.org/10.1021/jo011148j) and K. B. Sharpless (https://doi.org/10.1002/1521-3757(20020715)114:14<2708::AID-ANGE2708>3.0.CO;2-0).

The original paper from the Meldal lab describes the application of the CuAAC reaction for bioconjugation of protected saccharides to peptides, but application of the original ligand-free CuAAC procedure to more sensitive biomolecules like nucleic acids or to live cells have been limited. The main issues with the ligand-free CuAAC reaction in the early attempts for its biorthogonal application were the generation of reactive oxygen species (ROS) by the Cu (ii)/Cu (i) redox cycle and the toxicity of copper ions resulting from its coordination to amino acids. (https://doi.org/10.1021/ja2083027, https://doi.org/10.3390/molecules21101393).

To overcome these issues, ligand assisted CuAAC protocols have been developed and the field of research of copper ligands for CuAAC is still developing. A second strategy that is widely used for bioconjugations is strain promoted alkyne–azide cycloaddition (SPAAC) which proceeds fast enough even without copper (i) catalysis due to the ring strain relief of the used cyclic alkynes such as bicyclononyne (BCN).

This short article will focus on the former of the above mentioned strategies and will summarize the development and the current best ligands that limit the formation of ROS and the toxicity of Cu (i) ions, as well as considerably speed up the CuAAC reaction.

Types of CuAAC accelerating ligands

The classic ligand-free CuAAC reaction still uses amine bases such as triethylamine or DiPEA which can act as monodentate ligands for the Cu (i) ions, but due to the effect of these amines on the rate of the click reaction is negligible.

Polydentate amine ligands such as hexamethyltriethylenetetraamine (HMTETA), tris[2-(dimethylamino)ethyl]amine (Me6TREN) and pentamethyldiethylenetriamine (PMDTA) increase the rate of the CuAAC reaction significantly when used in 1:1 stoichiometric ratio with the copper (i) species. The rate coefficients for each ligand are given under the structure of each ligand (Figure 1). (https://doi.org/10.1021/ma061592u)

Figure 1: Structures of polydentate amines which can be used as ligands for CuAAC.
Figure 1: Structures of polydentate amines which can be used as ligands for CuAAC.

Since the copper (i) complexes are tetrahedral, the best results are achieved with tridentate ligands which occupy three of the four coordination spots and leave one free for the coordination of the alkyne. This can be seen from the relative rates of the CuAAC with PMDTA vs HMTETA as the ligand. The tridentate PMDTA increases the reaction rate about 4 times more than the tetradentate HMTETA.

In 2004, first tris-(triazole-ylmethyl)amine ligands were reported by the Fokin group (https://doi.org/10.1021/ol0493094) which have shown even higher increase in the reaction rate and the stabilization of the Cu (i) oxidation state with TBTA showing some of the best results. Optimization of the side chains connected to the triazole rings led to the development of several other tripodal triazole ligands with improved water solubility and Cu (i) stabilization. These include THPTA (https://doi.org/10.1002/anie.200905087), BTTAA (https://doi.org/10.1002/anie.201101817), BTTES (https://doi.org/10.1021/ja106553e), and some of the currently best performing ligands for CuAAC: BTTP and BTTPS (https://doi.org/10.1002/asia.201100385) (Figure 2).

Figure 2: Structures of tripodal polytriazole ligands developed for CuAAC reactions to be useful as biorthogonal reactions.
Figure 2: Structures of tripodal polytriazole ligands developed for CuAAC reactions to be useful as biorthogonal reactions.

Preparation of BTTP and BTTPS

The preparation of BTTP starts by a CuAAC reaction of tert-butylazide with diethylacetal of propiolaldehyde (3,3-diethoxyprop-1-yn). Two equivalents of the resulting triazole can be used in reductive alkylation of propargylamine and the last step is another CuAAC reaction with 3-azidopropan-1-ol. The corresponding sulphate (BTTPS) can be then prepared by treating BTTP with sulfur trioxide in pyridine (Figure 3). (https://doi.org/10.1002/asia.201100385) BTTES can be prepared similarly using 2-azidoethanol in the last click reaction. (https://doi.org/10.1021/ja106553e)

SigutLabs_Figure3
Figure 3: Synthesis of BTTP and BTTPS

Application in chemical biology

Ligand assisted CuAAC reaction has been used in many applications in chemical biology for bioconjugation of small molecules to proteins, glycans, lipids or nucleic acids as well as protein–protein coupling. (https://doi.org/10.3390/molecules21101393)

One example is fluorescent labelling of surface glycans on live cells which were first incubated with alkyne derivatives of sugars which the cell incorporates into the surface glycans. In this case, BTTES was used as the ligand (Figure 4). (https://doi.org/10.1021/ja106553e)

SigutLabs_Figure4
Figure 4: Fluorescent labelling of surface glycans by ligand assisted CuAAC reaction with BTTES as the ligand.
author foto
Krystof Sigut

OUR CASE STUDY

Scale-up to accelerate drug discovery

Our experience helped overcome development hurdles for potential cancer & mental health drugs.

Read more

Empowering neuro research with pro-N6pA

Sigut Labs scaled up pro-N6pA production, simplifying AMPylation research & boosting accessibility.

Read more

ADC development leaps with new linkers

Novel linker design expedited ADC advancement, leading to promising lead compounds faster.

Read more

Lincomycin derivative scale-up

Over 30 g of the desired product with exceptional purity was obtained through our optimized procedure.

Read more

Purifying 350 kg of vitamin K2 oil

Our innovative scale-up technology helped to reduce the client’s purification process from days to hours.

Read more

Our services

What we excel in so you don’t have to

View more
Thumbnail image Custom synthesis

Custom synthesis

Providing for a custom synthesis of previously reported molecules using described synthetic procedures.

Thumbnail image Contract research

Contract research

Developing novel synthetic routes to provide undescribed compounds in organic, bioorganic, and medicinal chemistry.

Thumbnail image Scale-Up

Scale-Up

Helping you go from lab scales to an industrial scale by applying our cutting-edge instrumentation.

Contact
Kryštof

Get in touch

Krystof Sigut, CEO and Founder
arrow

Our Experts

Profile image Krystof Sigut
Krystof Sigut
- CEO and Founder -
International chemical practitioner eager to restore Czech chemistry's global prestige. Contact Krystof for inquiries, NDA signing, or business matters.
Profile image Petr Slavik
Petr Slavik
- Head of Chemistry -
Synthetic chemistry pro with a decade's diverse lab expertise. For offers, research discussions, or detailed insights, reach out to Petr directly.

Partners & distributors

logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner